Introduction: in this study, it is aimed to emphasize the causes and importance of macrocytosis in paediatric practice. Methods: in the paediatric
Introduction
Erythrocytes are classified into three morphological groups by their mean cell volume (MCV): microcytic, normocytic, and macrocytic.
Macrocytosis is the enlargement of erythrocytes more than 2 standard deviations than the normal value of the age group. The classification by MCV also constitutes the foundation of anemia classification used mostly in clinical practice. Although MCV values vary by age and sex, reticulocyte count and other series are considered important for the examination of patients [1] . Macrocytic anemias are classified into two groups: one is associated with the megaloblastic changes in bone marrow and the other is non-megaloblastic anemia characterized by macrocytosis. Ninety five percent of megaloblastic anemias are caused by deficiency of vitamin B12 and/or folate. Whereas the most frequent causes of non-megaloblastic macrocytosis are neonatal period, reticulocytosis, liver dysfunction, aplastic anemias, and myelodysplastic syndromes [2, 3] . The aim of the present study is to 
Methods
Retrospective analysis of the clinical and laboratory findings of 1752 patients, who were examined in the paediatric hematology and oncology outpatient clinics in a one year period during JanuaryDecember 2017 were included. To identify the etiology, blood count, peripheral smear, bone-marrow aspiration and biopsies, erythrocyte sedimentation rate, kidney-liver-thyroid function tests, a-fetoprotein (AFP), hemoglobin F (HbF), vitamin B12 and folate levels were evaluated. Patients whose MCV values were more than 2 standard deviations than the normal value of the age group were grouped in macrocytosis. Etiology was investigated in these patients. There was any exclusion criteria in the study and variable datas are collected from our clinic archive. Prevalence rates of any severe hematological diseases such as acute leukemia and bone marrow deficiency were compared between macrocytic and normocytic or microcytic groups. 
Results
Macrocytosis was detected in 72 of 1752 patients. The mean age of patients with macrocytosis were 5.7 (3 months to 17 years) years and 44(61.2%) were male and 28(38.2%) were female. Eleven patients In the clinical and laboratory investigations of three (4.1) cases, no underlying cause that may lead to macrocytosis and no associated cytopenia were established. In 28 (84.8%) of 33 patients with DS and two (14.2%) of 14 patients with vitamin B12 deficiency no signs for cytopenia were observed. Of 25 patients with acute leukemia and bone marrow deficiency one had isolated mild thrombocytopenia, three had anemia, one neutropenia-leukopenia, and the remaining 20(80%) had either bicytopenia or pancytopenia. While one patient with acute leukemia had a moderate increase in liver function tests, one patient with DS was having treatment for hypothyroidism ( Table   1 ). The number of patients diagnosed with acute leukemia was 14(0.8%) in microcytic or normocytic group (n=1680) by MCV values.
Although patients with pancytopenia or bicytopenia caused by infections were included, they were not given the diagnosis of bone marrow deficiency. In the comparison of the macrocytic group to microcytic or normocytic group by MCV values, the prevalence of acute leukemia and bone marrow deficiency was found significantly higher in macrocytosis group (p< 0.001) ( Table 2 ). In the evaluation of the patients with Down syndrome within itself, of 106 patients with DS, 33(33.1%) had macrocytosis. Two patients with macrocytosis were diagnosed with AML-M6 and ALL at the time of the first admission. One patient was diagnosed with myelofibrosis based on bone marrow biopsy examined upon cytopenia and hypocellularity of bone marrow aspiration confirmed at outpatient follow up visit. This patient developed AML-M7, identified at follow up after 7 months. The comparison between the groups with and without macrocytosis showed that the prevalence of acute leukemia was significantly higher in patients with DS (Table 3) .
Discussion
Macrocytosis is caused by four main mechanisms. These include nutritional deficiencies, bone marrow disorders, medication, and chronic diseases [4] . Macrocytosis is rarely observed in children compared to normocytic or microcytic conditions, based on MCV [5] .
In our study, the prevalence of macrocytosis was 4.1% in 1752 patients. Although there are no studies on frequency in children in the literature, macrocytosis prevalence estimates ranging from 1.7% to 3.6% in adults [5, 6] . Our study had almost similar results when compared to the literature. Macrocytic anemias are classified as megaloblastic and non-megaloblastic. Non-megaloblastic anemia is associated with liver disease, hypothyroidism, bone marrow deficiencies, and MDS. The most common cause of megaloblastic anemia in children is vitamin B12 deficiency [5] . In our study, patients diagnosed with vitamin B12 deficiency were either suffering from accompanying iron deficiency or carriers of thalassemia, macrocytosis could only be identified in 14 patients. Failing to assess the utilization tests for vitamin B12 such as the measurements of serum concentrations of homocysteine and methylmalonic acid is considered as a limitation in diagnosing vitamin B12 deficiency. Pappo et al. [7] in their study in 146 children identified the causes of macrocytosis as of MCV decreases to 85 fL; over 6 months of age, the upper limit is calculated with MCV=84+0.6xAGE formula [8] . Patients in neonatal period were not included in our study. Individuals with Down syndrome also constitute a patient group with high prevalence for macrocytosis. In evaluation studies, macrocytosis was the most frequently obtained hematological finding in DS [9] . In a study by Prasher et al., macrocytosis was identified as the most frequent symptom in 147 adult patients [10] . In our cases, 33 of 106 patients with DS were determined to have macrocytosis. Two patients with macrocytosis had lower levels of vitamin B12. Since the levels of vitamin B12 and folic acid measurements were not performed in all DS cases with macrocytosis, no correlation between vitamin B12 and folic acid in this group of patients could be established. However, in previous studies, vitamin B12, and folic acid deficiency, and increased levels of hemoglobin F have not been determined as the underlying cause of macrocytosis in individuals with DS [11] .
Macrocytosis may be encountered as the earliest symptom in bone marrow deficiencies, and in MDS. Macrocytosis may be detected even in cases with normal blood count, and responsive to treatment [12] .
Macrocytosis and thrombocytopenia FAA are the most frequently obtained laboratory findings. Cytopenias usually occur at around the age of 5-10 years with a mean age of 7. In patients presenting with a congenital anomaly, and growth and developmental delay, if macrocytosis is present in blood count, then FAA should be suspected [13] . DBA and CDA are bone marrow deficiency syndromes, of which the former is associated with erythroid cell aplasia, and the latter is characterized by morphological abnormalities in erythrocytes and by ineffective erythropoiesis that affects isolated erythroid series.
Majority of the patients have macrocytic anemia [14] . In our study, seven FAA, two DBA, one aplastic anemia, and one CDA patient had cytopenia and macrocytosis in their blood counts performed for diagnostic assessment (Table 1) Anemia usually takes the form of normochromic normocytic anemia accompanied with reticulocytopenia [14] . In our study, of 28 patients diagnosed with acute leukemia, 14 (50%) had macrocytosis, and 14 (50%) had microcytic or normocytic MCV values. The prevalence for acute leukemia was higher in patients with macrocytosis (Table 2 ).
Compared to normal population, children with DS have an increased risk of developing acute leukemia and MDS [15] . Majority of the patients with lymphoid leukemia show immuno-phenotypic features of precursor B cell ALL. In patients with DS, unlike the myeloid leukemia, lymphoid leukemias are not observed during the period of infancy. Due to intrinsic drug resistance and treatment related mortalities, prognosis was worse than that of lymphoid leukemia, which occurs sporadically [16, 17] . The incidence of AML was found to be 150 times more in children with DS. The most common form of AML in children with DS is the AML-M7 acute mega karyoblastic leukemia [18] . AML-M6 and AML-M1/M2 are less frequent than AML-M7 in patients with DS [19, 20] . In our 106 cases with DS, three of them developed acute leukemia. They were diagnosed with AML-M6, AML-M7 and ALL. Within the patients with DS, comparison between the groups with and without macrocytosis showed a significantly higher incidence of acute leukemia (Table 3) .
Conclusion
Macrocytosis is a significant symptom in the diagnosis of bone marrow diseases and acute leukemia in childhood. Although, given the present conditions of our country, vitamin B12 deficiency is the first suspect in patients with cytopenia and macrocytosis, yet 
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